Proteomic profiling of acrolein adducts in human lung epithelial cells

Journal of Proteomics

Volumn 74, Issue 11, 2011, Pages 2380-2394

  Spiess, Page C ^a   Deng, Bin ^a   Hondal, Robert J ^a   Matthews, Dwight E ^a,b   van der Vliet, Albert ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Airway epithelium; Biotin hydrazide; Electrophile; Michael addition; Redox signaling; Thioredoxin reductase

Indexed keywords

ACROLEIN; BIOTIN; CYTOSKELETON PROTEIN; GLUTATHIONE TRANSFERASE; HEAT SHOCK PROTEIN; HYDRAZIDE; NUCLEOTIDE BINDING PROTEIN; SELENOCYSTEINE; THIOREDOXIN PEROXIDASE; THIOREDOXIN REDUCTASE;

ANIMAL CELL; ARTICLE; CATALYSIS; CELL LYSATE; CONTROLLED STUDY; ENZYME INACTIVATION; HUMAN; HUMAN CELL; LIQUID CHROMATOGRAPHY; LUNG ALVEOLUS EPITHELIUM; MASS SPECTROMETRY; MITOCHONDRION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PURIFICATION; PROTEIN TARGETING; PROTEOMICS; SIGNAL TRANSDUCTION;

ACROLEIN; AIR POLLUTANTS; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; EPITHELIAL CELLS; HUMANS; LUNG; MASS SPECTROMETRY; METABOLOME; MODELS, BIOLOGICAL; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; RESPIRATORY MUCOSA;

NICOTIANA TABACUM;

EID: 80052526211     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2011.05.039     Document Type: Article

References (76)

1. Leikauf G.D. Hazardous air pollutants and asthma. Environ Health Perspect 2002, 110(Suppl. 4):505-526.
2. Seaman V.Y., Charles M.J., Cahill T.M. A sensitive method for the quantification of acrolein and other volatile carbonyls in ambient air. Anal Chem 2006, 78(7):2405-2412.
3. Woodruff T.J., Wells E.M., Holt E.W., Burgin D.E., Axelrad D.A. Estimating risk from ambient concentrations of acrolein across the United States. Environ Health Perspect 2007, 115(3):410-415.
4. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991, 11:81-128.
5. Uchida K. Current staus of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 1999, 9:109-113.
6. Anderson M.M., Hazen S.L., Hsu F.F., Heinecke J.W. Human neutrophils employ the myeloperoxidase-hydrogen peroxide-chloride system to convert hydroxy-amino acids into glycolaldehyde, 2-hydroxypropanal, and acrolein. A mechanism for the generation of highly reactive alpha-hydroxy and alpha, beta-unsaturated aldehydes by phagocytes at sites of inflammation. J Clin Invest 1997, 99(3):424-432.
7. Kwak M.K., Kensler T.W., Casero R.A. Induction of phase 2 enzymes by serum oxidized polyamines through activation of Nrf2: effect of the polyamine metabolite acrolein. Biochem Biophys Res Commun 2003, 305(3):662-670.
8. Tanel A., Averill-Bates D.A. The aldehyde acrolein induces apoptosis via activation of the mitochondrial pathway. Biochim Biophys Acta 2005, 1743(3):255-267.
9. Li L., Holian A. Acrolein: a respiratory toxin that suppresses pulmonary host defense. Rev Environ Health 1998, 13(1-2):99-108.
10. Andreoli R., Manini P., Corradi M., Mutti A., Niessen W.M. Determination of patterns of biologically relevant aldehydes in exhaled breath condensate of healthy subjects by liquid chromatography/atmospheric chemical ionization tandem mass spectrometry. Rapid Commun Mass Spectrom 2003, 17(7):637-645.
11. Annovazzi L., Cattaneo V., Viglio S., Perani E., Zanone C., Rota C., et al. High-performance liquid chromatography and capillary electrophoresis: methodological challenges for the determination of biologically relevant low-aliphatic aldehydes in human saliva. Electrophoresis 2004, 25(9):1255-1263.
12. Kehrer J.P., Biswal S.S. The molecular effects of acrolein. Toxicol Sci 2000, 57:6-15.
13. Stevens J.F., Maier C.S. Acrolein: sources, metabolism, and biomolecular interactions relevant to human health and disease. Mol Nutr Food Res 2008, 52:7-25.
14. Feng Z., Hu W., Hu Y., Tang M.S. Acrolein is a major cigarette-related lung cancer agent: Preferential binding at p53 mutational hotspots and inhibition of DNA repair. Proc Natl Acad Sci USA 2006, 103(42):15404-15409.
15. Cai J., Bhatnagar A., Pierce W.M. Protein Modification by acrolein: formation and stability of cysteine adducts. Chem Res Toxicol 2009, 22:708-716.
16. Kern J.C., Kehrer J.P. Acrolein-induced cell death: a caspase-influenced decision between apoptosis and oncosis/necrosis. Chem Biol Interact 2002, 139(1):79-95.
17. Biswal S., Acquaah-Mensah G., Datta K., Wu X., Kehrer J.P. Inhibition of cell proliferation and AP-1 activity by acrolein in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem Res Toxicol 2002, 15(2):180-186.
18. Finkelstein E.I., Ruben J., Koot C.W., Hristova M., van der Vliet A. Regulation of constitutive neutrophil apoptosis by the α, Β-unsaturated aldehydes acrolein and 4-hydroxynonenal. Am J Physiol Lung Cell Mol Physiol 2005, 289:L1019-L1028.
19. Hristova M., Heuvelmans S., van der Vliet A. GSH-dependent regulation of Fas-mediated caspase-8 activation by acrolein. FEBS Lett 2007, 581(3):361-367.
20. Jaimes E.A., DeMaster E.G., Tian R.X., Raij L. Stable compounds of cigarette smoke induce endothelial superoxide anion production via NADPH oxidase activation. Arterioscler Thromb Vasc Biol 2004, 24(6):1031-1036.
21. Nardini M., Finkelstein E.I., Reddy S., Valacchi G., Traber M., Cross C.E., et al. Acrolein-induced cytotoxicity in cultured human bronchial epithelial cells. Modulation by alpha-tocopherol and ascorbic acid. Toxicology 2002, 170(3):173-185.
22. Luo J., Robinson J.P., Shi R. Acrolein-induced cell death in PC12 cells: role of mitochondria-mediated oxidative stress. Neurochem Int 2005, 47(7):449-457.
23. Berhane K., Widersten M., Engstrom A., Kozarich J.W., Mannervik B. Detoxication of base propenals and other alpha, beta-unsaturated aldehyde products of radical reactions and lipid peroxidation by human glutathione transferases. Proc Natl Acad Sci U S A 1994, 91(4):1480-1484.
24. Tjalkens R.B., Luckey S.W., Kroll D.J., Petersen D.R. Alpha, beta-unsaturated aldehydes increase glutathione S-transferase mRNA and protein: correlation with activation of the antioxidant response element. Arch Biochem Biophys 1998, 359(1):42-50.
25. Valacchi G., Pagnin E., Phung A., Nardini M., Schock B.C., Cross C.E., et al. Inhibition of NFkappaB activation and IL-8 expression in human bronchial epithelial cells by acrolein. Antioxid Redox Signal 2005, 7(1-2):25-31.
26. Horton N.D., Biswal S.S., Corrigan L.L., Bratta J., Kehrer J.P. Acrolein causes inhibitor kappaB-independent decreases in nuclear factor kappaB activation in human lung adenocarcinoma (A549) cells. J Biol Chem 1999, 274(14):9200-9206.
27. Lambert C., Li J., Jonscher K., Yang T.-C., Reigan P., Quintana M., et al. Acrolein inhibits cytokine gene expression by alkylating cysteine and arginine residues in the NF-κB1 DNA binding domain. J Biol Chem 2007, 282(27):19666-19675.
28. Wu R.P., Hayashi T., Cottam H.B., Jin G., Yao S., Wu C.C., et al. Nrf2 responses and the therapeutic selectivity of electrophilic compounds in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A 2010, 107(16):7479-7484.
29. Seiner D.R., LaButti J.N., Gates K.S. Kinetics and mechanism of protein tyrosine phosphatase 1B inactivation by acrolein. Chem Res Toxicol 2007, 20:1315-1320.
30. Go Y.-M., Halvey P.J., Hansen J.M., Reed M., Pohl J., Jones D.P. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol 2007, 171(5):1670-1681.
31. Myers C.R., Myers J.M. The effects of acrolein on peroxiredoxins, thioredoxins, and thioredoxin reductase in human bronchial epithelial cells. Toxicology 2009, 257:95-104.
32. Petersen D.R., Doorn J.A. Reactions of 4-hydroxynonenal with proteins and cellular targets. Free Radic Biol Med 2004, 37(7):937-945.
33. Leonarduzzi G., Robbesyn F., Poli G. Signaling kinases modulated by 4-hydroxynonenal. Free Radic Biol Med 2004, 37(11):1694-1702.
34. Liu H., Li W., Ahmad M., Miller T.M., Rose M.E., Poloyac S.M., et al. Modification of ubiquitin-C-terminal hydrolase-L1 by cyclopentenone prostaglandins exacerbates hypoxic injury. Neurobiol Dis 2011, 41(2):318-328.
35. Doyle K., Fitzpatrick F.A. Redox signaling, alkylation (carbonylation) of conserved cysteines inactivates class I histone deacetylases 1, 2, and 3 and antagonizes their transcriptional repressor function. J Biol Chem 2010, 285(23):17417-17424.
36. Kim D.H., Kim E.H., Na H.K., Sun Y., Surh Y.J. 15-Deoxy-Delta(12,14)-prostaglandin J(2) stabilizes, but functionally inactivates p53 by binding to the cysteine 277 residue. Oncogene 2010, 29(17):2560-2576.
37. Uchida K., Shibata T. 15-Deoxy-Delta(12,14)-prostaglandin J2: an electrophilic trigger of cellular responses. Chem Res Toxicol 2008, 21(1):138-144.
38. Kim E.H., Surh Y.J. 15-deoxy-Delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors. Biochem Pharmacol 2006, 72(11):1516-1528.
39. Zhang H., Forman H.J. Signaling pathways involved in phase II gene induction by alpha, beta-unsaturated aldehydes. Toxicol Ind Health 2009, 25(4-5):269-278.
40. Sarkar P., Hayes B.E. Proteomic profiling of rat lung epithelial cells induced by acrolein. Life Sci 2009, 85:188-195.
41. Thompson C.A., Burcham P.C. Genome-wide transcriptional responses to acrolein. Chem Res Toxicol 2008, 21:2245-2256.
42. Uchida K., Itakura K., Kawakishi S., Hiai H., Toyokuni S., Stadtman E.R. Characterization of epitopes recognized by 4-hydroxy-2-nonenal specific antibodies. Arch Biochem Biophys 1995, 324:241-248.
43. Levonen A.L., Landar A., Ramachandran A., Ceaser E.K., Dickinson D.A., Zanoni G., et al. Cellular mechanisms of redox cell signaling: role of cysteine modification controlling antioxidant defenses in response to electrophilic lipid oxidation products. Biochem J 2004, 378:373-382.
44. Parola M., Robino G., Marra F., Pinzani M., Bellomo G., Leonarduzzi G., et al. HNE interacts directly with JNK isoforms in human hepatic stellate cells. J Clin Invest 1998, 102:1942-1950.
45. Furuhata A., Ishii T., Kumazawa S., Yamada T., Nakayama T., Uchida K. N(epsilon)-(3-methylpyridinium) lysine, a major antigenic adduct generated in acrolein-modified protein. J Biol Chem 2003, 278:48658-48665.
46. Shao B., Fu X., McDonald T.O., Green P.S., Uchida K., O'Brien K.D., et al. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I. J Biol Chem 2005, 280(43):36386-36396.
47. Codreanu S.G., Zhang B., Sobecki S.M., Billheimer D.D., Liebler D.C. Global analysis of protein damage by the lipid electrophile 4-hydroxy-2-nonenal. Mol Cell Proteomics 2009, 8:670-680.
48. Mirzaei M., Regnier F.E. Affinity chromatographic selection of carbonylated proteins followed by identification of oxidation sites using tandem mass spectrometry. Anal Chem 2005, 77(8):2386-2392.
49. Landar A., Oh J.-Y., Giles N.M., Isom A., Kirk M., Barnes S., et al. A sensitive method for the quantitative measurement of protein thiol modification in response to oxidative stress. Free Radic Biol Med 2006, 40:459-468.
50. Gayarre J., Stamatakis K., Renedo M., Perez-Sala D. Differential selectivity of protein modification by the cyclopentenone prostaglandins PGA1 and 15-deoxy-Delta12,14-PGJ2: role of glutathione. FEBS Lett 2005, 579(25):5803-5808.
51. Jacobs A.T., Marnett L.J. Systems analysis of protein modification and cellular responses induced by electrophile stress. Acc Chem Res 2010, 43(5):673-683.
52. Conrad C.C., Choi J., Malakowsky C.A., Talent J.M., Dai R., Marshall P., et al. Identification of protein carbonyls after two-dimensional electrophoresis. Proteomics 2001, 1(7):829-834.
53. Mello C.F., Sultana R., Piroddi M., Cai J., Pierce W.M., Klein J.B., et al. Acrolein induces selective protein carbonylation in synaptosomes. Neuroscience 2007, 147:674-679.
54. Roe M.R., Xie H., Bandhakavi S., Griffin T.J. Proteomic mapping of 4-hydroxynonenal protein modification sites by solid-phase hydrazide chemistry and mass spectrometry. Anal Biochem 2007, 79:3747-3756.
55. Eckenroth B., Harris K., Turanov A.A., Gladyshev V.N., Raines R.T., Hondal R.J. Semisynthesis and characterization of mammalian thioredoxin reductase. Biochemistry 2006, 45:5158-5170.
56. Wu R., Zhao Y.H., Chang M.M. Growth and differentiation of conducting airway epithelial cells in culture. Eur Respir J 1997, 10(10):2398-2403.
57. Medina I., Carbonell J., Pulido L., Madeira S.C., Goetz S., Conesa A., et al. Babelomics: an integrative platform for the analysis of transcriptomics, proteomics and genomic data with advanced functional profiling. Nucleic Acids Res 2010, 38:210-213.
58. Szadkowski A., Myers C.R. Acrolein oxidizes the cytosolic and mitochondiral thioredoxins in human endothelial cells. Toxicology 2008, 243:164-176.
59. Holmgren A., Bjornstedt M. Thioredoxin and thioredoxin reductase. Methods Enzymol 1995, 252:199-208.
60. Stadtman E.R., Berlett B.S. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol 1997, 10(5):485-494.
61. Arner E.S. Selenoproteins-What unique properties can arise with selenocysteine in place of cysteine?. Exp Cell Res 2010, 316(8):1296-1303.
62. Conklin D.J., Haberzettl P., Prough R.A., Bhatnagar A. Glutathione-S-transferase P protects against endothelial dysfunction induced by exposure to tobacco smoke. Am J Physiol Heart Circ Physiol 2009, 296:H1586-H1597.
63. LoPachin R.M., Gavin T., Petersen D.R., Barber D.S. Molecular mechanisms of 4-hydroxy-2-nonenal and acrolein toxicity: nucleophilic targets and adduct formation. Chem Res Toxicol 2009, 22(9):1499-1508.
64. Hao G., Derakhshan B., Shi L., Campagne F., Gross S.S. SNOSID, a proteomic method for identification of cysteine S-nitrosylation sites in complex protein mixtures. Proc Natl Acad Sci U S A 2006, 103(4):1012-1017.
65. Dalle-Donne I., Carini M., Vistoli G., Gamberoni L., Giustarini D., Colombo R., et al. Actin Cys374 as a nucleophilic target of α, β-unsaturated aldehydes. Free Radic Biol Med 2007, 42:583-598.
66. Dalle-Donne I., Scaloni A., Giustarini D., Cavarra E., Tell G., Lungarella G., et al. Proteins as biomarkers of oxidative/nitrosative stress in diseases: the contribution of redox proteomics. Mass Spectrom Rev 2005, 24:55-99.
67. Borisov O.V., Goshe M.B., Conrads T.P., Rakov V.S., Veenstra T.D., Smith R.D. Low-energy collision-induced dissociation fragmentation analysis of cysteinyl-modified peptides. Anal Chem 2002, 74(10):2284-2292.
68. Yoo B.-S., Regnier F.E. Proteomic analysis of carbonylated proteins in two-dimensional electrophoresis using avidin-fluorescein afiinity staining. Electrophoresis 2004, 25:1334-1341.
69. Nordberg J., Zhong L., Holmgren A., Arnér E.S. Mammalian thioredoxin reductase is irreversibly inhibited by dinitrohalobenzenes by alkylation of both the redox active selenocysteine and its neighboring cysteine residue. J Biol Chem 1998, 273:10835-10842.
70. Anestal K., Arner E.S. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine. J Biol Chem 2003, 278:15966-15972.
71. Anestal K., Prast-Nielsen S., Cenas N., Arner E.S.J. Cell death by SecTRAPs: thioredoxin reductase as a prooxidant killer of cells. PLoS One 2008, 3(4):e1846.
72. Cassidy P.B., Edes K., Nelson C.C., Parsawar K., Fitzpatrick F.A., Moos P.J. Thioredoxin reductase is required for the inactivation of tumor suppressor p53 and for apoptosis induced by endogenous electrophiles. Carcinogenesis 2006, 27(12):2538-2549.
73. Huber R.E., Criddle R.S. Comparison of the chemical properties of selenocysteine and selenocystine with their sulfur analogs. Arch Biochem Biophys 1967, 122(1):164-173.
74. Danehy J.P., Noel C.J. The relative nucleophilic character of several mercaptans toward ethylene oxide. J Am Chem Soc 1960, 82:2511-2515.
75. Mugesh G., Sing H.B. Synthetic organoselenium compounds as antioxidants: glutathione peroxidase activity. Chem Soc Rev 2000, 29:347-357.
76. Lee S.R., Bar-Noy S., Kwon J., Levine R.L., Stadtman T.C., Rhee S.G. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity. Proc Natl Acad Sci USA 2000, 97(6):2521-2526.